Alleva DG[au] - Search Results

Year	Number of Results
1993	4
1994	4
1995	2
1997	3
1998	2
2000	1
2001	2
2002	3
2003	1
2004	2
2005	2
2006	2
2014	1
2020	1
2021	1
2022	1

1

Development of an IgG-Fc fusion COVID-19 subunit vaccine, AKS-452.

Alleva DG, Delpero AR, Scully MM, Murikipudi S, Ragupathy R, Greaves EK, Sathiyaseelan T, Haworth JR, Shah NJ, Rao V, Nagre S, Lancaster TM, Webb SS, Jasa AI, Ronca SE, Green FM, Elyard HA, Yee J, Klein J, Karnes L, Sollie F, Zion TC. Alleva DG, et al. Vaccine. 2021 Oct 29;39(45):6601-6613. doi: 10.1016/j.vaccine.2021.09.077. Epub 2021 Oct 5. Vaccine. 2021. PMID: 34642088 Free PMC article.

2

Tumor-induced immune dysfunction: the macrophage connection.

Elgert KD, Alleva DG, Mullins DW. Elgert KD, et al. Among authors: alleva dg. J Leukoc Biol. 1998 Sep;64(3):275-90. doi: 10.1002/jlb.64.3.275. J Leukoc Biol. 1998. PMID: 9738653 Review.

3

Reversal of Hyperglycemia and Suppression of Type 1 Diabetes in the NOD Mouse with Apoptotic DNA Immunotherapy™ (ADi™), ADi-100.

Alleva DG, Rezaee M, Yip L, Ren G, Rosenberg J, Concepcion W, Escher A, Shabahang S, Thakor AS. Alleva DG, et al. Biomedicines. 2020 Mar 4;8(3):53. doi: 10.3390/biomedicines8030053. Biomedicines. 2020. PMID: 32143316 Free PMC article.

4

Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452.

Janssen YF, Feitsma EA, Boersma HH, Alleva DG, Lancaster TM, Sathiyaseelan T, Murikipudi S, Delpero AR, Scully MM, Ragupathy R, Kotha S, Haworth JR, Shah NJ, Rao V, Nagre S, Ronca SE, Green FM, Aminetzah A, Sollie F, Kruijff S, Brom M, van Dam GM, Zion TC. Janssen YF, et al. Among authors: alleva dg. Vaccine. 2022 Feb 23;40(9):1253-1260. doi: 10.1016/j.vaccine.2022.01.043. Epub 2022 Jan 31. Vaccine. 2022. PMID: 35115195 Free PMC article. Clinical Trial.

5

Experimental autoimmune encephalomyelitis develops in CC chemokine receptor 7-deficient mice with altered T-cell responses.

Pahuja A, Maki RA, Hevezi PA, Chen A, Verge GM, Lechner SM, Roth RB, Zlotnik A, Alleva DG. Pahuja A, et al. Among authors: alleva dg. Scand J Immunol. 2006 Oct;64(4):361-9. doi: 10.1111/j.1365-3083.2006.01787.x. Scand J Immunol. 2006. PMID: 16970675 Free article.

6

Identification of CC chemokine receptor 7 residues important for receptor activation.

Ott TR, Pahuja A, Nickolls SA, Alleva DG, Struthers RS. Ott TR, et al. Among authors: alleva dg. J Biol Chem. 2004 Oct 8;279(41):42383-92. doi: 10.1074/jbc.M401097200. Epub 2004 Jul 28. J Biol Chem. 2004. PMID: 15284247 Free article.

7

Enhanced early innate and T cell-mediated responses in subjects immunized with Anthrax Vaccine Adsorbed Plus CPG 7909 (AV7909).

Minang JT, Inglefield JR, Harris AM, Lathey JL, Alleva DG, Sweeney DL, Hopkins RJ, Lacy MJ, Bernton EW. Minang JT, et al. Among authors: alleva dg. Vaccine. 2014 Nov 28;32(50):6847-54. doi: 10.1016/j.vaccine.2014.01.096. Epub 2014 Feb 13. Vaccine. 2014. PMID: 24530403 Free PMC article. Clinical Trial.

8

Immunomodulation in type 1 diabetes by NBI-6024, an altered peptide ligand of the insulin B epitope.

Alleva DG, Maki RA, Putnam AL, Robinson JM, Kipnes MS, Dandona P, Marks JB, Simmons DL, Greenbaum CJ, Jimenez RG, Conlon PJ, Gottlieb PA. Alleva DG, et al. Scand J Immunol. 2006 Jan;63(1):59-69. doi: 10.1111/j.1365-3083.2005.01705.x. Scand J Immunol. 2006. PMID: 16398702 Free article. Clinical Trial.

9

Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonist.

Heise CE, Pahuja A, Hudson SC, Mistry MS, Putnam AL, Gross MM, Gottlieb PA, Wade WS, Kiankarimi M, Schwarz D, Crowe P, Zlotnik A, Alleva DG. Heise CE, et al. Among authors: alleva dg. J Pharmacol Exp Ther. 2005 Jun;313(3):1263-71. doi: 10.1124/jpet.105.083683. Epub 2005 Mar 10. J Pharmacol Exp Ther. 2005. PMID: 15761110

10

A high-throughput chemotaxis assay for pharmacological characterization of chemokine receptors: Utilization of U937 monocytic cells.

Ott TR, Pahuja A, Lio FM, Mistry MS, Gross M, Hudson SC, Wade WS, Simpson PB, Struthers RS, Alleva DG. Ott TR, et al. Among authors: alleva dg. J Pharmacol Toxicol Methods. 2005 Mar-Apr;51(2):105-14. doi: 10.1016/j.vascn.2004.10.001. Epub 2004 Nov 5. J Pharmacol Toxicol Methods. 2005. PMID: 15767203

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results